Description

• • A blend of Tesamorelin (5mg), MGF (500mcg), and Ipamorelin (2.5mg) studied for its role in regulating growth hormone (GH) secretion and cellular processes.
  • Tesamorelin has been researched for its effects on GH release and lipid metabolism.
  • MGF (Mechano Growth Factor) has been explored for its potential role in cellular signaling and tissue studies.
  • Ipamorelin interacts with the ghrelin receptor, influencing GH secretion while minimizing interactions with other endocrine pathways.
  • This combination is commonly utilized in controlled research settings to evaluate GH-related responses and cellular mechanisms.